METACLAZEPAM
UNII C2N2B1303L

Substance Identification & Data

This profile provides standardized clinical and technical data for Metaclazepam, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C2N2B1303L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 84031-17-4 and the RxNorm Concept ID (RxCUI) 614654. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

C2N2B1303L

CAS Registry Number

84031-17-4

RxNorm Concept ID

614654

Detailed Substance Profile

Preferred Name

METACLAZEPAM

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H18BrClN2O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WABYCCJHARSRBH-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C83941

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

71272

Unique identification number in the NCBI database of chemical substances.

INN ID

4495

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c(c(Cl)ccc1)C=2c3c(ccc(c3)Br)N(C)C(CN2)COC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Metaclazepam. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.